Regulation of complement factor H in a human liver cell line by interferon-gamma

Scand J Immunol. 1999 May;49(5):487-94. doi: 10.1046/j.1365-3083.1999.00528.x.

Abstract

Factor H is a regulatory protein of the alternative pathway of complement activation. The liver is the major site of synthesis. We have used the Hep3b human liver cell line as a model for examining its regulation by interferon-gamma (IFN-gamma). The maximal response was achieved at 50 U/ml of IFN-gamma. An increase in H mRNA was observed as early as 2 h after addition of IFN-gamma; the response peaked at 24 h. The half-life of H mRNA in the presence of IFN-gamma was 3.8 +/- 0.8 h. The increase in H mRNA by IFN-gamma was partly dependent on protein synthesis, as cycloheximide (CHX) reduced the response by 40% and the level of H mRNA decreased in a dose-dependent manner with increasing concentrations of CHX. Phosphorylation events were also important in this induction because the kinase inhibitors staurosporine and genistein inhibited the induction of H mRNA by 88% and 68%, respectively. The induction could be inhibited completely when Hep3b cells were treated with CHX and staurosporine. Thus induction of factor H by IFN-gamma apparently involves two factors. One is likely to be Stat1alpha and the other is a CHX-sensitive protein.

MeSH terms

  • Complement Factor H / biosynthesis*
  • Complement Factor H / genetics
  • Cycloheximide / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Inhibitors / pharmacology
  • Gene Expression Regulation / drug effects
  • Humans
  • Interferon-gamma / metabolism*
  • Interferon-gamma / pharmacology
  • Kinetics
  • Liver / cytology
  • Liver / metabolism*
  • Protein Biosynthesis
  • Protein Kinase Inhibitors
  • Protein Synthesis Inhibitors / pharmacology
  • RNA, Messenger
  • Staurosporine / pharmacology
  • Time Factors
  • Tumor Cells, Cultured

Substances

  • CFH protein, human
  • Enzyme Inhibitors
  • Protein Kinase Inhibitors
  • Protein Synthesis Inhibitors
  • RNA, Messenger
  • Complement Factor H
  • Interferon-gamma
  • Cycloheximide
  • Staurosporine